Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) recently said that one of its units plans to sell up to 419 million shares, representing 14.45% stake in Tianjin Tianhai Investment Co., Ltd. (SHSE:900938).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 CNY | -0.46% | -2.27% | -17.94% |
1st Jan change | Capi. | |
---|---|---|
-17.94% | 806M | |
+18.66% | 114B | |
-4.51% | 30B | |
+5.38% | 20.85B | |
-9.61% | 19.13B | |
-3.11% | 17.48B | |
+22.84% | 17.26B | |
+16.37% | 13.14B | |
+4.46% | 12.69B | |
+28.83% | 9.24B |
- Stock Market
- Equities
- 600751 Stock
- News HNA Technology Co.,Ltd.
- Hubei Biocause Pharmaceutical To Sell 14.45% Stake In Tianjin Tianhai Investment